2025 - Introduced
Virginia H.B.1765
  • Prohibits health insurers from imposing cost-sharing, prior authorization, step therapy, or other coverage limitations on a covered FDA-approved non-opioid drug.
2025 - Introduced
Virginia S.B.800
  • Ensures that no non-opioid approved by the FDA shall be disadvantaged or discouraged relative to opioids, including through prior authorization or step therapy.
2024 - Introduced
Washington H.B.1034
  • Prohibits health insurers from imposing restrictive practices that disadvantage or discourage the use of non-opioid drugs for the treatment of pain relative to opioid drugs.
2025 - Introduced
West Virginia H.B. 3070/S.B. 628
  • Prohibits West Virginia's Medicaid and commercial health insurance formularies or preferred drug lists from disadvantaging or discouraging a non-opioid drug with respect to coverage of an opioid drug, including through more restrictive coverage criteria, utilization management, or cost sharing.
  • Requires the West Virginia Bureau of Public Health develop educational materials about non-opioid alternatives for the treatment of acute pain.